Cell Reprogramming in Hematopoiesis and Immunity
51 – 60 of 67
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Compositions for reprogramming cells into plasmacytoid dendritic cells or interferon producing cells, methods and uses thereof
(2021) WO2021069672
- Patent › Patent
-
Mark
Reprogramming Stars #1 : Genome Programming through the Cell Cycle - An Interview with Dr. Tomomi Tsubouchi
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming, the Journal
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
- Contribution to journal › Scientific review
-
Mark
Ontogenic shifts in cellular fate are linked to proteotype changes in lineage-biased hematopoietic progenitor cells
- Contribution to journal › Article
-
Mark
Restoring the immunogenicity of cancer cells with dendritic cell reprogramming
- Contribution to journal › Published meeting abstract
-
Mark
GATA2 at the mitosis-to-G1 transition is critical for definitive hematopoiesis
(2021) 2021 Virtual Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology: ISEH 50th Annual Meeting In Experimental Hematology 100(Suppl). p.35-35
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
A SOX2 reporter system identifies gastric cancer stem-like cells sensitive to monensin
- Contribution to journal › Article
-
Mark
Mononuclear phagocyte regulation by the transcription factor Blimp-1 in health and disease
- Contribution to journal › Scientific review
-
Mark
Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors
- Contribution to journal › Article
